GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the M69V E166A double mutant of shv-1 B-lactamase complexed to clavulanic acid

Analyse Crystal structure of the M69V E166A double mutant of shv-1 B-lactamase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2H0T
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Broad-spectrum beta-lactamase shv-1
EC
3.5.2.6
UniProt
Q5PSW7
Ligands
MA4, TEM
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABroad-spectrum beta-lactamase shv-1 (EC 3.5.2.6)protein26545% helix, 17% strandQ5PSW7

Ligands and binding sites

  • MA4 · Cyclohexyl-hexyl-beta-D-maltoside · ligand · 2 copies · chains A
  • TEM · N-(2-hydroxy-4-oxo-butyl)-N-(3-oxo-transpropenyl)amine · ligand · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12050.680.8523MA4
2620.290.7415TEM, EPE

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 2H0T · Crystal structure of the M69V E166A double mutant of SHV-1 b-lactamase complexed to… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.